Performance Dynamics of Beximco Pharmaceuticals Ltd
Historical Background
Beximco Pharma is a leading edge pharmaceutical company and is a member of the Beximco Group,the largest private sector industrial conglomerate in Bangladesh. The firm started operation in 1980,manufacturing products under the licenses of Bayer AG of Germany and Upjohn Inc. of USA andnow have grown to become nation 's one of the leading pharmaceutical companies, supplying morethan 10% of country 's total medicine need. Today Beximco Pharma manufactures and markets its own`branded generics ' for almost all diseases from AIDS to cancer, from infection to asthma, fromhypertension to diabetes for both national and international markets.
Company Profile
Beximco Pharma manufactures a range of dosage forms including tablets, capsules, dry syrup,powder, cream, ointment, suppositories, large volume intravenous fluids, metered dose inhalers etc. inseveral world-class manufacturing plants, ensuring high quality standards complying with the WorldHealth Organization (WHO) approved current Good Manufacturing Practices (cGMP). They alsocontract manufacture for major international brands of leading multinational companies.
Organizational Structure
BPL is completely governed and maintained by a corporate body. The chief of theorganization is the Chief Executive Officer and the total operation is divided into Marketing,Sales, Commercial, Manufacturing, Finance and Accounting, Product Planning, BusinessResearch and Development, and MIS departments each supervised by a director. Directors of thedepartments report directly to the CEO.Bearing the demands of dynamic environment in mind BPL designed its organizational structure ashighly adaptive and flexible. It is a Learning Organization that has developed the capacity tocontinuously learn, adapt and change. In BPL employees are highly trained and empowered to handlediverse job activities and problems. They have minimal formalization with narrow span of control.The
Beximco Pharma is a leading edge pharmaceutical company and is a member of the Beximco Group,the largest private sector industrial conglomerate in Bangladesh. The firm started operation in 1980,manufacturing products under the licenses of Bayer AG of Germany and Upjohn Inc. of USA andnow have grown to become nation 's one of the leading pharmaceutical companies, supplying morethan 10% of country 's total medicine need. Today Beximco Pharma manufactures and markets its own`branded generics ' for almost all diseases from AIDS to cancer, from infection to asthma, fromhypertension to diabetes for both national and international markets.
Company Profile
Beximco Pharma manufactures a range of dosage forms including tablets, capsules, dry syrup,powder, cream, ointment, suppositories, large volume intravenous fluids, metered dose inhalers etc. inseveral world-class manufacturing plants, ensuring high quality standards complying with the WorldHealth Organization (WHO) approved current Good Manufacturing Practices (cGMP). They alsocontract manufacture for major international brands of leading multinational companies.
Organizational Structure
BPL is completely governed and maintained by a corporate body. The chief of theorganization is the Chief Executive Officer and the total operation is divided into Marketing,Sales, Commercial, Manufacturing, Finance and Accounting, Product Planning, BusinessResearch and Development, and MIS departments each supervised by a director. Directors of thedepartments report directly to the CEO.Bearing the demands of dynamic environment in mind BPL designed its organizational structure ashighly adaptive and flexible. It is a Learning Organization that has developed the capacity tocontinuously learn, adapt and change. In BPL employees are highly trained and empowered to handlediverse job activities and problems. They have minimal formalization with narrow span of control.The